Global Cell Therapy CDMO Services Market Research Report 2026(Status and Outlook)
Cell therapy refers to the transfer of new cells, or cells that have been modified in a laboratory to achieve particular characteristics, into the body to prevent or treat a disease. A Contract Development and Manufacturing Organization (CDMO) is a company that provides comprehensive services to pharmaceutical, biotechnology, and medical device companies. CDMOs offer contract services for product development, formulation, manufacturing, packaging, and distribution. Contract development and manufacturing organizations (CDMOs) play a vital role in cell therapy development by offering crucial infrastructure and expertise.This report mainly focuses on cell therapy CDMO services market.The cell therapy CDMO market is mainly concentrated in the following regions: North America (especially the United States) is the leader in the global cell therapy CDMO market, with advanced technology, a sound regulatory system and a large number of biopharmaceutical companies. The active support of the US FDA for cell therapy has also driven the growth of the market in the region. The European market also performed strongly, mainly due to the EU's support for cell therapy research and development and the regulatory framework of the EMA (European Medicines Agency). The United Kingdom, Germany and Switzerland are the main markets in Europe. The Asia-Pacific region (especially China, Japan and South Korea) is one of the fastest growing markets. The Chinese government's policy support and financial investment in the field of cell therapy, as well as Japan's leading position in regenerative medicine, have driven the rapid development of the market in the region. The markets in Latin America and the Middle East are relatively small, but with the popularization of cell therapy technology and the improvement of medical infrastructure, the market potential in these regions is gradually being released.Challenges and Opportunities:Challenges: The manufacturing process of cell therapy products is complex, requires high quality control, and is expensive. In addition, the instability of the global supply chain and the shortage of raw materials may also affect the delivery of CDMO services. Opportunities: With the advancement of technology and the optimization of manufacturing processes, CDMO companies have the opportunity to further expand their market share by providing efficient and low-cost services. In addition, the rise of emerging markets and the growing demand for personalized medicine have also provided new growth points for CDMO companies.
The global Cell Therapy CDMO Services market size was estimated at USD 2135.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 21.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell Therapy CDMO Services market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell Therapy CDMO Services market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell Therapy CDMO Services market.
Global Cell Therapy CDMO Services Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Charles River Laboratories
AGC Biologics
FUJIFILM Cellular Dynamics
Thermo Fisher Scientific
Wuxi AppTec
Lonza
KBI Biopharma
RoslinCT
Cell and Gene Therapy Catapult
Cell Therapies
Minaris Regenerative Medicine
MEDINET
Catalent Biologics
Oxford BioMedica
GenScript
Cell-Easy
SK pharmteco
Market Segmentation (by Type)
Preclinical Stage
Clinical Commercialization Stage
Market Segmentation (by Application)
Pharmaceutical Company
Research Institute
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell Therapy CDMO Services Market
Overview of the regional outlook of the Cell Therapy CDMO Services Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Therapy CDMO Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell Therapy CDMO Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Cell Therapy CDMO Services market size was estimated at USD 2135.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 21.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell Therapy CDMO Services market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell Therapy CDMO Services market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell Therapy CDMO Services market.
Global Cell Therapy CDMO Services Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Charles River Laboratories
AGC Biologics
FUJIFILM Cellular Dynamics
Thermo Fisher Scientific
Wuxi AppTec
Lonza
KBI Biopharma
RoslinCT
Cell and Gene Therapy Catapult
Cell Therapies
Minaris Regenerative Medicine
MEDINET
Catalent Biologics
Oxford BioMedica
GenScript
Cell-Easy
SK pharmteco
Market Segmentation (by Type)
Preclinical Stage
Clinical Commercialization Stage
Market Segmentation (by Application)
Pharmaceutical Company
Research Institute
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell Therapy CDMO Services Market
Overview of the regional outlook of the Cell Therapy CDMO Services Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Therapy CDMO Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell Therapy CDMO Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell Therapy CDMO Services
1.2 Key Market Segments
1.2.1 Cell Therapy CDMO Services Segment by Type
1.2.2 Cell Therapy CDMO Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL THERAPY CDMO SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL THERAPY CDMO SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell Therapy CDMO Services Product Life Cycle
3.3 Global Cell Therapy CDMO Services Revenue Market Share by Company (2020-2025)
3.4 Cell Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Cell Therapy CDMO Services Market Competitive Situation and Trends
3.6.1 Cell Therapy CDMO Services Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell Therapy CDMO Services Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL THERAPY CDMO SERVICES VALUE CHAIN ANALYSIS
4.1 Cell Therapy CDMO Services Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL THERAPY CDMO SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell Therapy CDMO Services Market Porter's Five Forces Analysis
6 CELL THERAPY CDMO SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Therapy CDMO Services Market by Type (2020-2025)
6.3 Global Cell Therapy CDMO Services Market Size Growth Rate by Type (2021-2025)
7 CELL THERAPY CDMO SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Therapy CDMO Services Market Size (M USD) by Application (2020-2025)
7.3 Global Cell Therapy CDMO Services Market Size Growth Rate by Application (2021-2025)
8 CELL THERAPY CDMO SERVICES MARKET SEGMENTATION BY REGION
8.1 Global Cell Therapy CDMO Services Market Size by Region
8.1.1 Global Cell Therapy CDMO Services Market Size by Region
8.1.2 Global Cell Therapy CDMO Services Market Size Market Share by Region
8.2 North America
8.2.1 North America Cell Therapy CDMO Services Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell Therapy CDMO Services Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Cell Therapy CDMO Services Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell Therapy CDMO Services Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell Therapy CDMO Services Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Charles River Laboratories
9.1.1 Charles River Laboratories Basic Information
9.1.2 Charles River Laboratories Cell Therapy CDMO Services Product Overview
9.1.3 Charles River Laboratories Cell Therapy CDMO Services Product Market Performance
9.1.4 Charles River Laboratories SWOT Analysis
9.1.5 Charles River Laboratories Business Overview
9.1.6 Charles River Laboratories Recent Developments
9.2 AGC Biologics
9.2.1 AGC Biologics Basic Information
9.2.2 AGC Biologics Cell Therapy CDMO Services Product Overview
9.2.3 AGC Biologics Cell Therapy CDMO Services Product Market Performance
9.2.4 AGC Biologics SWOT Analysis
9.2.5 AGC Biologics Business Overview
9.2.6 AGC Biologics Recent Developments
9.3 FUJIFILM Cellular Dynamics
9.3.1 FUJIFILM Cellular Dynamics Basic Information
9.3.2 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Overview
9.3.3 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Market Performance
9.3.4 FUJIFILM Cellular Dynamics SWOT Analysis
9.3.5 FUJIFILM Cellular Dynamics Business Overview
9.3.6 FUJIFILM Cellular Dynamics Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Basic Information
9.4.2 Thermo Fisher Scientific Cell Therapy CDMO Services Product Overview
9.4.3 Thermo Fisher Scientific Cell Therapy CDMO Services Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 Wuxi AppTec
9.5.1 Wuxi AppTec Basic Information
9.5.2 Wuxi AppTec Cell Therapy CDMO Services Product Overview
9.5.3 Wuxi AppTec Cell Therapy CDMO Services Product Market Performance
9.5.4 Wuxi AppTec Business Overview
9.5.5 Wuxi AppTec Recent Developments
9.6 Lonza
9.6.1 Lonza Basic Information
9.6.2 Lonza Cell Therapy CDMO Services Product Overview
9.6.3 Lonza Cell Therapy CDMO Services Product Market Performance
9.6.4 Lonza Business Overview
9.6.5 Lonza Recent Developments
9.7 KBI Biopharma
9.7.1 KBI Biopharma Basic Information
9.7.2 KBI Biopharma Cell Therapy CDMO Services Product Overview
9.7.3 KBI Biopharma Cell Therapy CDMO Services Product Market Performance
9.7.4 KBI Biopharma Business Overview
9.7.5 KBI Biopharma Recent Developments
9.8 RoslinCT
9.8.1 RoslinCT Basic Information
9.8.2 RoslinCT Cell Therapy CDMO Services Product Overview
9.8.3 RoslinCT Cell Therapy CDMO Services Product Market Performance
9.8.4 RoslinCT Business Overview
9.8.5 RoslinCT Recent Developments
9.9 Cell and Gene Therapy Catapult
9.9.1 Cell and Gene Therapy Catapult Basic Information
9.9.2 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Overview
9.9.3 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Market Performance
9.9.4 Cell and Gene Therapy Catapult Business Overview
9.9.5 Cell and Gene Therapy Catapult Recent Developments
9.10 Cell Therapies
9.10.1 Cell Therapies Basic Information
9.10.2 Cell Therapies Cell Therapy CDMO Services Product Overview
9.10.3 Cell Therapies Cell Therapy CDMO Services Product Market Performance
9.10.4 Cell Therapies Business Overview
9.10.5 Cell Therapies Recent Developments
9.11 Minaris Regenerative Medicine
9.11.1 Minaris Regenerative Medicine Basic Information
9.11.2 Minaris Regenerative Medicine Cell Therapy CDMO Services Product Overview
9.11.3 Minaris Regenerative Medicine Cell Therapy CDMO Services Product Market Performance
9.11.4 Minaris Regenerative Medicine Business Overview
9.11.5 Minaris Regenerative Medicine Recent Developments
9.12 MEDINET
9.12.1 MEDINET Basic Information
9.12.2 MEDINET Cell Therapy CDMO Services Product Overview
9.12.3 MEDINET Cell Therapy CDMO Services Product Market Performance
9.12.4 MEDINET Business Overview
9.12.5 MEDINET Recent Developments
9.13 Catalent Biologics
9.13.1 Catalent Biologics Basic Information
9.13.2 Catalent Biologics Cell Therapy CDMO Services Product Overview
9.13.3 Catalent Biologics Cell Therapy CDMO Services Product Market Performance
9.13.4 Catalent Biologics Business Overview
9.13.5 Catalent Biologics Recent Developments
9.14 Oxford BioMedica
9.14.1 Oxford BioMedica Basic Information
9.14.2 Oxford BioMedica Cell Therapy CDMO Services Product Overview
9.14.3 Oxford BioMedica Cell Therapy CDMO Services Product Market Performance
9.14.4 Oxford BioMedica Business Overview
9.14.5 Oxford BioMedica Recent Developments
9.15 GenScript
9.15.1 GenScript Basic Information
9.15.2 GenScript Cell Therapy CDMO Services Product Overview
9.15.3 GenScript Cell Therapy CDMO Services Product Market Performance
9.15.4 GenScript Business Overview
9.15.5 GenScript Recent Developments
9.16 Cell-Easy
9.16.1 Cell-Easy Basic Information
9.16.2 Cell-Easy Cell Therapy CDMO Services Product Overview
9.16.3 Cell-Easy Cell Therapy CDMO Services Product Market Performance
9.16.4 Cell-Easy Business Overview
9.16.5 Cell-Easy Recent Developments
9.17 SK pharmteco
9.17.1 SK pharmteco Basic Information
9.17.2 SK pharmteco Cell Therapy CDMO Services Product Overview
9.17.3 SK pharmteco Cell Therapy CDMO Services Product Market Performance
9.17.4 SK pharmteco Business Overview
9.17.5 SK pharmteco Recent Developments
10 CELL THERAPY CDMO SERVICES MARKET FORECAST BY REGION
10.1 Global Cell Therapy CDMO Services Market Size Forecast
10.2 Global Cell Therapy CDMO Services Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell Therapy CDMO Services Market Size Forecast by Country
10.2.3 Asia Pacific Cell Therapy CDMO Services Market Size Forecast by Region
10.2.4 South America Cell Therapy CDMO Services Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Cell Therapy CDMO Services by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Cell Therapy CDMO Services Market Forecast by Type (2026-2035)
11.1.1 Global Cell Therapy CDMO Services Market Size Forecast by Type (2026-2035)
11.2 Global Cell Therapy CDMO Services Market Forecast by Application (2026-2035)
11.2.1 Global Cell Therapy CDMO Services Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell Therapy CDMO Services
1.2 Key Market Segments
1.2.1 Cell Therapy CDMO Services Segment by Type
1.2.2 Cell Therapy CDMO Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL THERAPY CDMO SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL THERAPY CDMO SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell Therapy CDMO Services Product Life Cycle
3.3 Global Cell Therapy CDMO Services Revenue Market Share by Company (2020-2025)
3.4 Cell Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Cell Therapy CDMO Services Market Competitive Situation and Trends
3.6.1 Cell Therapy CDMO Services Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell Therapy CDMO Services Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL THERAPY CDMO SERVICES VALUE CHAIN ANALYSIS
4.1 Cell Therapy CDMO Services Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL THERAPY CDMO SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell Therapy CDMO Services Market Porter's Five Forces Analysis
6 CELL THERAPY CDMO SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Therapy CDMO Services Market by Type (2020-2025)
6.3 Global Cell Therapy CDMO Services Market Size Growth Rate by Type (2021-2025)
7 CELL THERAPY CDMO SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Therapy CDMO Services Market Size (M USD) by Application (2020-2025)
7.3 Global Cell Therapy CDMO Services Market Size Growth Rate by Application (2021-2025)
8 CELL THERAPY CDMO SERVICES MARKET SEGMENTATION BY REGION
8.1 Global Cell Therapy CDMO Services Market Size by Region
8.1.1 Global Cell Therapy CDMO Services Market Size by Region
8.1.2 Global Cell Therapy CDMO Services Market Size Market Share by Region
8.2 North America
8.2.1 North America Cell Therapy CDMO Services Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell Therapy CDMO Services Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Cell Therapy CDMO Services Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell Therapy CDMO Services Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell Therapy CDMO Services Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Charles River Laboratories
9.1.1 Charles River Laboratories Basic Information
9.1.2 Charles River Laboratories Cell Therapy CDMO Services Product Overview
9.1.3 Charles River Laboratories Cell Therapy CDMO Services Product Market Performance
9.1.4 Charles River Laboratories SWOT Analysis
9.1.5 Charles River Laboratories Business Overview
9.1.6 Charles River Laboratories Recent Developments
9.2 AGC Biologics
9.2.1 AGC Biologics Basic Information
9.2.2 AGC Biologics Cell Therapy CDMO Services Product Overview
9.2.3 AGC Biologics Cell Therapy CDMO Services Product Market Performance
9.2.4 AGC Biologics SWOT Analysis
9.2.5 AGC Biologics Business Overview
9.2.6 AGC Biologics Recent Developments
9.3 FUJIFILM Cellular Dynamics
9.3.1 FUJIFILM Cellular Dynamics Basic Information
9.3.2 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Overview
9.3.3 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Market Performance
9.3.4 FUJIFILM Cellular Dynamics SWOT Analysis
9.3.5 FUJIFILM Cellular Dynamics Business Overview
9.3.6 FUJIFILM Cellular Dynamics Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Basic Information
9.4.2 Thermo Fisher Scientific Cell Therapy CDMO Services Product Overview
9.4.3 Thermo Fisher Scientific Cell Therapy CDMO Services Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 Wuxi AppTec
9.5.1 Wuxi AppTec Basic Information
9.5.2 Wuxi AppTec Cell Therapy CDMO Services Product Overview
9.5.3 Wuxi AppTec Cell Therapy CDMO Services Product Market Performance
9.5.4 Wuxi AppTec Business Overview
9.5.5 Wuxi AppTec Recent Developments
9.6 Lonza
9.6.1 Lonza Basic Information
9.6.2 Lonza Cell Therapy CDMO Services Product Overview
9.6.3 Lonza Cell Therapy CDMO Services Product Market Performance
9.6.4 Lonza Business Overview
9.6.5 Lonza Recent Developments
9.7 KBI Biopharma
9.7.1 KBI Biopharma Basic Information
9.7.2 KBI Biopharma Cell Therapy CDMO Services Product Overview
9.7.3 KBI Biopharma Cell Therapy CDMO Services Product Market Performance
9.7.4 KBI Biopharma Business Overview
9.7.5 KBI Biopharma Recent Developments
9.8 RoslinCT
9.8.1 RoslinCT Basic Information
9.8.2 RoslinCT Cell Therapy CDMO Services Product Overview
9.8.3 RoslinCT Cell Therapy CDMO Services Product Market Performance
9.8.4 RoslinCT Business Overview
9.8.5 RoslinCT Recent Developments
9.9 Cell and Gene Therapy Catapult
9.9.1 Cell and Gene Therapy Catapult Basic Information
9.9.2 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Overview
9.9.3 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Market Performance
9.9.4 Cell and Gene Therapy Catapult Business Overview
9.9.5 Cell and Gene Therapy Catapult Recent Developments
9.10 Cell Therapies
9.10.1 Cell Therapies Basic Information
9.10.2 Cell Therapies Cell Therapy CDMO Services Product Overview
9.10.3 Cell Therapies Cell Therapy CDMO Services Product Market Performance
9.10.4 Cell Therapies Business Overview
9.10.5 Cell Therapies Recent Developments
9.11 Minaris Regenerative Medicine
9.11.1 Minaris Regenerative Medicine Basic Information
9.11.2 Minaris Regenerative Medicine Cell Therapy CDMO Services Product Overview
9.11.3 Minaris Regenerative Medicine Cell Therapy CDMO Services Product Market Performance
9.11.4 Minaris Regenerative Medicine Business Overview
9.11.5 Minaris Regenerative Medicine Recent Developments
9.12 MEDINET
9.12.1 MEDINET Basic Information
9.12.2 MEDINET Cell Therapy CDMO Services Product Overview
9.12.3 MEDINET Cell Therapy CDMO Services Product Market Performance
9.12.4 MEDINET Business Overview
9.12.5 MEDINET Recent Developments
9.13 Catalent Biologics
9.13.1 Catalent Biologics Basic Information
9.13.2 Catalent Biologics Cell Therapy CDMO Services Product Overview
9.13.3 Catalent Biologics Cell Therapy CDMO Services Product Market Performance
9.13.4 Catalent Biologics Business Overview
9.13.5 Catalent Biologics Recent Developments
9.14 Oxford BioMedica
9.14.1 Oxford BioMedica Basic Information
9.14.2 Oxford BioMedica Cell Therapy CDMO Services Product Overview
9.14.3 Oxford BioMedica Cell Therapy CDMO Services Product Market Performance
9.14.4 Oxford BioMedica Business Overview
9.14.5 Oxford BioMedica Recent Developments
9.15 GenScript
9.15.1 GenScript Basic Information
9.15.2 GenScript Cell Therapy CDMO Services Product Overview
9.15.3 GenScript Cell Therapy CDMO Services Product Market Performance
9.15.4 GenScript Business Overview
9.15.5 GenScript Recent Developments
9.16 Cell-Easy
9.16.1 Cell-Easy Basic Information
9.16.2 Cell-Easy Cell Therapy CDMO Services Product Overview
9.16.3 Cell-Easy Cell Therapy CDMO Services Product Market Performance
9.16.4 Cell-Easy Business Overview
9.16.5 Cell-Easy Recent Developments
9.17 SK pharmteco
9.17.1 SK pharmteco Basic Information
9.17.2 SK pharmteco Cell Therapy CDMO Services Product Overview
9.17.3 SK pharmteco Cell Therapy CDMO Services Product Market Performance
9.17.4 SK pharmteco Business Overview
9.17.5 SK pharmteco Recent Developments
10 CELL THERAPY CDMO SERVICES MARKET FORECAST BY REGION
10.1 Global Cell Therapy CDMO Services Market Size Forecast
10.2 Global Cell Therapy CDMO Services Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell Therapy CDMO Services Market Size Forecast by Country
10.2.3 Asia Pacific Cell Therapy CDMO Services Market Size Forecast by Region
10.2.4 South America Cell Therapy CDMO Services Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Cell Therapy CDMO Services by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Cell Therapy CDMO Services Market Forecast by Type (2026-2035)
11.1.1 Global Cell Therapy CDMO Services Market Size Forecast by Type (2026-2035)
11.2 Global Cell Therapy CDMO Services Market Forecast by Application (2026-2035)
11.2.1 Global Cell Therapy CDMO Services Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell Therapy CDMO Services Market Size by Type (M USD)
Table 4. Global Cell Therapy CDMO Services Market Size by Application
Table 5. Cell Therapy CDMO Services Market Size Comparison by Region (M USD)
Table 6. Global Cell Therapy CDMO Services Revenue (M USD) by Company (2020-2025)
Table 7. Global Cell Therapy CDMO Services Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO Services as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Cell Therapy CDMO Services Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Cell Therapy CDMO Services Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Cell Therapy CDMO Services Market Size by Type (M USD)
Table 22. Global Cell Therapy CDMO Services Market Size (M USD) by Type (2020-2025)
Table 23. Global Cell Therapy CDMO Services Market Share by Type (2020-2025)
Table 24. Global Cell Therapy CDMO Services Market Size Growth Rate by Type (2021-2025)
Table 25. Global Cell Therapy CDMO Services Market Size by Application
Table 26. Global Cell Therapy CDMO Services Market Size by Application (2020-2025) & (M USD)
Table 27. Global Cell Therapy CDMO Services Market Share by Application (2020-2025)
Table 28. Global Cell Therapy CDMO Services Market Size Growth Rate by Application (2021-2025)
Table 29. Global Cell Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 30. Global Cell Therapy CDMO Services Market Size Market Share by Region (2020-2025)
Table 31. North America Cell Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Cell Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Cell Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 34. South America Cell Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Cell Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 36. Charles River Laboratories Basic Information
Table 37. Charles River Laboratories Cell Therapy CDMO Services Product Overview
Table 38. Charles River Laboratories Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Charles River Laboratories SWOT Analysis
Table 40. Charles River Laboratories Business Overview
Table 41. Charles River Laboratories Recent Developments
Table 42. AGC Biologics Basic Information
Table 43. AGC Biologics Cell Therapy CDMO Services Product Overview
Table 44. AGC Biologics Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 45. AGC Biologics SWOT Analysis
Table 46. AGC Biologics Business Overview
Table 47. AGC Biologics Recent Developments
Table 48. FUJIFILM Cellular Dynamics Basic Information
Table 49. FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Overview
Table 50. FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 51. FUJIFILM Cellular Dynamics SWOT Analysis
Table 52. FUJIFILM Cellular Dynamics Business Overview
Table 53. FUJIFILM Cellular Dynamics Recent Developments
Table 54. Thermo Fisher Scientific Basic Information
Table 55. Thermo Fisher Scientific Cell Therapy CDMO Services Product Overview
Table 56. Thermo Fisher Scientific Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. Wuxi AppTec Basic Information
Table 60. Wuxi AppTec Cell Therapy CDMO Services Product Overview
Table 61. Wuxi AppTec Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Wuxi AppTec Business Overview
Table 63. Wuxi AppTec Recent Developments
Table 64. Lonza Basic Information
Table 65. Lonza Cell Therapy CDMO Services Product Overview
Table 66. Lonza Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Lonza Business Overview
Table 68. Lonza Recent Developments
Table 69. KBI Biopharma Basic Information
Table 70. KBI Biopharma Cell Therapy CDMO Services Product Overview
Table 71. KBI Biopharma Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 72. KBI Biopharma Business Overview
Table 73. KBI Biopharma Recent Developments
Table 74. RoslinCT Basic Information
Table 75. RoslinCT Cell Therapy CDMO Services Product Overview
Table 76. RoslinCT Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 77. RoslinCT Business Overview
Table 78. RoslinCT Recent Developments
Table 79. Cell and Gene Therapy Catapult Basic Information
Table 80. Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Overview
Table 81. Cell and Gene Therapy Catapult Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Cell and Gene Therapy Catapult Business Overview
Table 83. Cell and Gene Therapy Catapult Recent Developments
Table 84. Cell Therapies Basic Information
Table 85. Cell Therapies Cell Therapy CDMO Services Product Overview
Table 86. Cell Therapies Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Cell Therapies Business Overview
Table 88. Cell Therapies Recent Developments
Table 89. Minaris Regenerative Medicine Basic Information
Table 90. Minaris Regenerative Medicine Cell Therapy CDMO Services Product Overview
Table 91. Minaris Regenerative Medicine Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Minaris Regenerative Medicine Business Overview
Table 93. Minaris Regenerative Medicine Recent Developments
Table 94. MEDINET Basic Information
Table 95. MEDINET Cell Therapy CDMO Services Product Overview
Table 96. MEDINET Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 97. MEDINET Business Overview
Table 98. MEDINET Recent Developments
Table 99. Catalent Biologics Basic Information
Table 100. Catalent Biologics Cell Therapy CDMO Services Product Overview
Table 101. Catalent Biologics Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Catalent Biologics Business Overview
Table 103. Catalent Biologics Recent Developments
Table 104. Oxford BioMedica Basic Information
Table 105. Oxford BioMedica Cell Therapy CDMO Services Product Overview
Table 106. Oxford BioMedica Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Oxford BioMedica Business Overview
Table 108. Oxford BioMedica Recent Developments
Table 109. GenScript Basic Information
Table 110. GenScript Cell Therapy CDMO Services Product Overview
Table 111. GenScript Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 112. GenScript Business Overview
Table 113. GenScript Recent Developments
Table 114. Cell-Easy Basic Information
Table 115. Cell-Easy Cell Therapy CDMO Services Product Overview
Table 116. Cell-Easy Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Cell-Easy Business Overview
Table 118. Cell-Easy Recent Developments
Table 119. SK pharmteco Basic Information
Table 120. SK pharmteco Cell Therapy CDMO Services Product Overview
Table 121. SK pharmteco Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 122. SK pharmteco Business Overview
Table 123. SK pharmteco Recent Developments
Table 124. Global Cell Therapy CDMO Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 125. North America Cell Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Europe Cell Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Asia Pacific Cell Therapy CDMO Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Cell Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Middle East and Africa Cell Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Global Cell Therapy CDMO Services Market Size Forecast by Type (2026-2035) & (M USD)
Table 131. Global Cell Therapy CDMO Services Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell Therapy CDMO Services Market Size by Type (M USD)
Table 4. Global Cell Therapy CDMO Services Market Size by Application
Table 5. Cell Therapy CDMO Services Market Size Comparison by Region (M USD)
Table 6. Global Cell Therapy CDMO Services Revenue (M USD) by Company (2020-2025)
Table 7. Global Cell Therapy CDMO Services Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO Services as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Cell Therapy CDMO Services Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Cell Therapy CDMO Services Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Cell Therapy CDMO Services Market Size by Type (M USD)
Table 22. Global Cell Therapy CDMO Services Market Size (M USD) by Type (2020-2025)
Table 23. Global Cell Therapy CDMO Services Market Share by Type (2020-2025)
Table 24. Global Cell Therapy CDMO Services Market Size Growth Rate by Type (2021-2025)
Table 25. Global Cell Therapy CDMO Services Market Size by Application
Table 26. Global Cell Therapy CDMO Services Market Size by Application (2020-2025) & (M USD)
Table 27. Global Cell Therapy CDMO Services Market Share by Application (2020-2025)
Table 28. Global Cell Therapy CDMO Services Market Size Growth Rate by Application (2021-2025)
Table 29. Global Cell Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 30. Global Cell Therapy CDMO Services Market Size Market Share by Region (2020-2025)
Table 31. North America Cell Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Cell Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Cell Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 34. South America Cell Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Cell Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 36. Charles River Laboratories Basic Information
Table 37. Charles River Laboratories Cell Therapy CDMO Services Product Overview
Table 38. Charles River Laboratories Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Charles River Laboratories SWOT Analysis
Table 40. Charles River Laboratories Business Overview
Table 41. Charles River Laboratories Recent Developments
Table 42. AGC Biologics Basic Information
Table 43. AGC Biologics Cell Therapy CDMO Services Product Overview
Table 44. AGC Biologics Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 45. AGC Biologics SWOT Analysis
Table 46. AGC Biologics Business Overview
Table 47. AGC Biologics Recent Developments
Table 48. FUJIFILM Cellular Dynamics Basic Information
Table 49. FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Overview
Table 50. FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 51. FUJIFILM Cellular Dynamics SWOT Analysis
Table 52. FUJIFILM Cellular Dynamics Business Overview
Table 53. FUJIFILM Cellular Dynamics Recent Developments
Table 54. Thermo Fisher Scientific Basic Information
Table 55. Thermo Fisher Scientific Cell Therapy CDMO Services Product Overview
Table 56. Thermo Fisher Scientific Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. Wuxi AppTec Basic Information
Table 60. Wuxi AppTec Cell Therapy CDMO Services Product Overview
Table 61. Wuxi AppTec Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Wuxi AppTec Business Overview
Table 63. Wuxi AppTec Recent Developments
Table 64. Lonza Basic Information
Table 65. Lonza Cell Therapy CDMO Services Product Overview
Table 66. Lonza Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Lonza Business Overview
Table 68. Lonza Recent Developments
Table 69. KBI Biopharma Basic Information
Table 70. KBI Biopharma Cell Therapy CDMO Services Product Overview
Table 71. KBI Biopharma Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 72. KBI Biopharma Business Overview
Table 73. KBI Biopharma Recent Developments
Table 74. RoslinCT Basic Information
Table 75. RoslinCT Cell Therapy CDMO Services Product Overview
Table 76. RoslinCT Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 77. RoslinCT Business Overview
Table 78. RoslinCT Recent Developments
Table 79. Cell and Gene Therapy Catapult Basic Information
Table 80. Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Overview
Table 81. Cell and Gene Therapy Catapult Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Cell and Gene Therapy Catapult Business Overview
Table 83. Cell and Gene Therapy Catapult Recent Developments
Table 84. Cell Therapies Basic Information
Table 85. Cell Therapies Cell Therapy CDMO Services Product Overview
Table 86. Cell Therapies Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Cell Therapies Business Overview
Table 88. Cell Therapies Recent Developments
Table 89. Minaris Regenerative Medicine Basic Information
Table 90. Minaris Regenerative Medicine Cell Therapy CDMO Services Product Overview
Table 91. Minaris Regenerative Medicine Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Minaris Regenerative Medicine Business Overview
Table 93. Minaris Regenerative Medicine Recent Developments
Table 94. MEDINET Basic Information
Table 95. MEDINET Cell Therapy CDMO Services Product Overview
Table 96. MEDINET Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 97. MEDINET Business Overview
Table 98. MEDINET Recent Developments
Table 99. Catalent Biologics Basic Information
Table 100. Catalent Biologics Cell Therapy CDMO Services Product Overview
Table 101. Catalent Biologics Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Catalent Biologics Business Overview
Table 103. Catalent Biologics Recent Developments
Table 104. Oxford BioMedica Basic Information
Table 105. Oxford BioMedica Cell Therapy CDMO Services Product Overview
Table 106. Oxford BioMedica Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Oxford BioMedica Business Overview
Table 108. Oxford BioMedica Recent Developments
Table 109. GenScript Basic Information
Table 110. GenScript Cell Therapy CDMO Services Product Overview
Table 111. GenScript Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 112. GenScript Business Overview
Table 113. GenScript Recent Developments
Table 114. Cell-Easy Basic Information
Table 115. Cell-Easy Cell Therapy CDMO Services Product Overview
Table 116. Cell-Easy Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Cell-Easy Business Overview
Table 118. Cell-Easy Recent Developments
Table 119. SK pharmteco Basic Information
Table 120. SK pharmteco Cell Therapy CDMO Services Product Overview
Table 121. SK pharmteco Cell Therapy CDMO Services Revenue (M USD) and Gross Margin (2020-2025)
Table 122. SK pharmteco Business Overview
Table 123. SK pharmteco Recent Developments
Table 124. Global Cell Therapy CDMO Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 125. North America Cell Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Europe Cell Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Asia Pacific Cell Therapy CDMO Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Cell Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Middle East and Africa Cell Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Global Cell Therapy CDMO Services Market Size Forecast by Type (2026-2035) & (M USD)
Table 131. Global Cell Therapy CDMO Services Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Cell Therapy CDMO Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Therapy CDMO Services Market Size (M USD), 2025-2035
Figure 5. Global Cell Therapy CDMO Services Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Cell Therapy CDMO Services Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Cell Therapy CDMO Services Product Life Cycle
Figure 12. Global Cell Therapy CDMO Services Revenue Share by Company in 2025
Figure 13. Cell Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Cell Therapy CDMO Services Revenue in 2025
Figure 15. Value Chain Map of Cell Therapy CDMO Services
Figure 16. Global Cell Therapy CDMO Services Market PEST Analysis
Figure 17. Global Cell Therapy CDMO Services Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Cell Therapy CDMO Services Market Share by Type
Figure 20. Market Share of Cell Therapy CDMO Services by Type (2020-2025)
Figure 21. Global Cell Therapy CDMO Services Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell Therapy CDMO Services Market Share by Application
Figure 24. Global Cell Therapy CDMO Services Market Share by Application (2020-2025)
Figure 25. Global Cell Therapy CDMO Services Market Share by Application in 2024
Figure 26. Global Cell Therapy CDMO Services Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Cell Therapy CDMO Services Market Size Market Share by Region (2020-2025)
Figure 28. North America Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Cell Therapy CDMO Services Market Size Market Share by Country in 2024
Figure 30. U.S. Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Cell Therapy CDMO Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Cell Therapy CDMO Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Cell Therapy CDMO Services Market Share by Country in 2024
Figure 35. Germany Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Cell Therapy CDMO Services Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Cell Therapy CDMO Services Market Size Market Share by Region in 2024
Figure 42. China Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Cell Therapy CDMO Services Market Size and Growth Rate (M USD)
Figure 48. South America Cell Therapy CDMO Services Market Size Market Share by Country in 2024
Figure 49. Brazil Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Cell Therapy CDMO Services Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Cell Therapy CDMO Services Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Cell Therapy CDMO Services Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Cell Therapy CDMO Services Market Share Forecast by Type (2026-2035)
Figure 61. Global Cell Therapy CDMO Services Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Cell Therapy CDMO Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Therapy CDMO Services Market Size (M USD), 2025-2035
Figure 5. Global Cell Therapy CDMO Services Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Cell Therapy CDMO Services Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Cell Therapy CDMO Services Product Life Cycle
Figure 12. Global Cell Therapy CDMO Services Revenue Share by Company in 2025
Figure 13. Cell Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Cell Therapy CDMO Services Revenue in 2025
Figure 15. Value Chain Map of Cell Therapy CDMO Services
Figure 16. Global Cell Therapy CDMO Services Market PEST Analysis
Figure 17. Global Cell Therapy CDMO Services Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Cell Therapy CDMO Services Market Share by Type
Figure 20. Market Share of Cell Therapy CDMO Services by Type (2020-2025)
Figure 21. Global Cell Therapy CDMO Services Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell Therapy CDMO Services Market Share by Application
Figure 24. Global Cell Therapy CDMO Services Market Share by Application (2020-2025)
Figure 25. Global Cell Therapy CDMO Services Market Share by Application in 2024
Figure 26. Global Cell Therapy CDMO Services Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Cell Therapy CDMO Services Market Size Market Share by Region (2020-2025)
Figure 28. North America Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Cell Therapy CDMO Services Market Size Market Share by Country in 2024
Figure 30. U.S. Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Cell Therapy CDMO Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Cell Therapy CDMO Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Cell Therapy CDMO Services Market Share by Country in 2024
Figure 35. Germany Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Cell Therapy CDMO Services Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Cell Therapy CDMO Services Market Size Market Share by Region in 2024
Figure 42. China Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Cell Therapy CDMO Services Market Size and Growth Rate (M USD)
Figure 48. South America Cell Therapy CDMO Services Market Size Market Share by Country in 2024
Figure 49. Brazil Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Cell Therapy CDMO Services Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Cell Therapy CDMO Services Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Cell Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Cell Therapy CDMO Services Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Cell Therapy CDMO Services Market Share Forecast by Type (2026-2035)
Figure 61. Global Cell Therapy CDMO Services Market Share Forecast by Application (2026-2035)
